910P Assessment of early detection by multi-omics-based liquid biopsy in lung cancer: A prospective study (ASCEND-LUNG)

Abstract

Liquid biopsy offers an optimal approach for the early detection of lung cancer that is the leading cause of cancer mortality worldwide. Here, we report the results of AssesSment of early-deteCtion basEd oN liquiD biopsy in LUNG cancer (ASCEND-LUNG, NCT04817046), a prospective study designed to develop early detection models for lung cancer based on multi-omics assays including cell-free DNA (cfDNA) methylation, mutation, and tumor proteins.